Optum Rx To Reduce Reauthorization Requirements For 40 More Drugs

On January 1, 2026, Optum Rx will reduce reauthorizations for an additional 40 drugs, building on its effort to minimize the overall quantity of reauthorization requirements, according to a recent announcement. Optum Rx is also expanding PreCheck Prior Authorization, its solution that automates the creation and approval of prior authorizations, shortening approval time from 8.5 hours to under 30 seconds.

Earlier in 2025, Optum Rx launched efforts to eliminate reauthorizations for chronic condition medications. Among the new group of drugs to be included, Optum Rx added hormone therapy and knee osteoarthritis injectables. There are now 180 medications with reduced . . .